SCHW
62
-2
ADSK
66
-4
HUM
41
-4
ED
45
3
LEN
50
-2
HAS
30
-2
MRO
50
4
WDC
37
-3
PCAR
56
-5
NOC
41
9
NAVI
52
-2
STX
45
-4
NEM
40
3
VMC
53
-4
AAPL
40
-6
C
62
4
PAYX
48
-6
AXP
67
-2
SWK
50
-5
REGN
38
-2
SCHW
62
-2
ADSK
66
-4
HUM
41
-4
ED
45
3
LEN
50
-2
HAS
30
-2
MRO
50
4
WDC
37
-3
PCAR
56
-5
NOC
41
9
NAVI
52
-2
STX
45
-4
NEM
40
3
VMC
53
-4
AAPL
40
-6
C
62
4
PAYX
48
-6
AXP
67
-2
SWK
50
-5
REGN
38
-2
Financhill
Back

JPMorgan BetaBuilders US Aggt Bond ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
41

BBAG
JPMorgan BetaBuilders US Aggt Bond ETF

Last Price:
45.60
Seasonality Move:
0.49%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
41
JPMorgan BetaBuilders US Aggt Bond ETF (BBAG) is a Sell

Is JPMorgan BetaBuilders US Aggt Bond ETF a Buy, Sell or Hold?

  • The current JPMorgan BetaBuilders US Aggt Bond ETF [BBAG] share price is $45.58. The Score for BBAG is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • BBAG is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BBAG Stock Price Chart

What is JPMorgan BetaBuilders US Aggt Bond ETF's stock price today?

  • The JPMorgan BetaBuilders US Aggt Bond ETF share price today is $45.58
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BBAG is experiencing slight buying pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

BBAG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.26 Sell
Relative Strength Index (14 RSI): 36.48 Sell
Chaikin Money Flow: 79352 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (45.66 - 46.32) Sell
Bollinger Bands (100): (45.78 - 47.12) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

BBAG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 45.69 Sell
20-day SMA: 45.85 Sell
50-day SMA: 46.58 Sell
200-day SMA: 45.91 Sell
8-day EMA: 45.68 Sell
20-day EMA: 45.9 Sell
50-day EMA: 46.25 Sell
200-day EMA: 46.09 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

JPMorgan BetaBuilders US Aggt Bond ETF Earnings Growth & BBAG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

JPMorgan BetaBuilders US Aggt Bond ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):